Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.9% sodium chloride[2] Chloride ion,
Sodium chloride		[1] D02056 --[4] 6, 14, 51, 53
210% intravenous immunoglobulin (IVIg)[1] Human immunoglobulin G---[1] 14
310% liquid formulation of human immunoglobulin----[1] 14
4: immunoglobulina umana normale 10% per somministrazione endovenosa----[1] 14
5Act-HiB[1] Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---[4] 14, 61, 62, 222
6Acthar[1] Corticotropin[1] D00146 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[9] 2, 13, 14, 46, 49, 50, 66, 84, 222
7Albumin (Human) 25%, United States Pharmacopeia (USP)----[2] 13, 14
8Anti-C5 antibody----[4] 11, 14, 62, 109
9Anti-Thymocyte Globulin----[18] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285
10ARGX-113----[5] 11, 14, 35, 53, 63
11ARGX-117----[1] 14
12ARGX-117 IV----[1] 14
13Batoclimab[1] Batoclimab[1] D11983 [1] FCGRT 💬-[2] 11, 14
14Batoclimab 340 mg SC weekly[1] Batoclimab[1] D11983 [1] FCGRT 💬-[2] 11, 14
15Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly[1] Batoclimab[1] D11983 [1] FCGRT 💬-[1] 14
16Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)[1] Human immunoglobulin G---[1] 14
17BIVV020----[2] 14, 61
18Carmustine[1] Carmustine[1] D00254 --[5] 11, 13, 14, 28, 60
19Chloride[1] Chloride ion---[28] 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
20Clorfenamina[1] Chlorpheniramine[1] D07398 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 14
21CLORFENAMINA MALEATO[1] Chlorpheniramine[1] D07398 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 14
22Cyclophosphamide[1] Cyclophosphamide[2] D00287 ,
D07760 		--[44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331
23Cytarabine[1] Cytarabine[1] D00168 --[7] 11, 13, 14, 25, 49, 60, 65
24Dexamethasone[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[22] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
25Drug:----[3] 14, 46, 113
26ECULIZUMAB[1] Eculizumab[1] D03940 [1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[7] 11, 13, 14, 61, 62, 109, 222
27EFGARTIGIMOD ALFA[1] Efgartigimod alfa[1] D11876 [1] FCGRT 💬-[6] 11, 14, 35, 53, 63, 162
28Efgartigimod PH20 SC----[5] 11, 14, 35, 63, 162
29Efgartigimod PH20 SC in stage B----[1] 14
30Etoposide[1] Etoposide[1] D00125 [2] TOP2A,
TOP2B 💬		[1] Platinum drug resistance 💬[11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331
31FAMPRIDINE[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 13, 14
32FAMPYRA[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 13, 14
33Fibrinogen[1] Fibrinogen human---[2] 14, 65
34Fibrinogen concentrate[1] Fibrinogen human---[1] 14
35FINGOLIMOD[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 14, 156
36FINGOLIMOD HYDROCHLORIDE[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14
37Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)[1] Human immunoglobulin G---[3] 14, 43, 45
38FTY720----[2] 13, 14
39FTY720I----[1] 14
40Gammanorm----[2] 14, 65
41Gilenya----[3] 2, 13, 14
42GILENYA 0,5 mg cápsulas duras[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 14
43Group C meningococcal conjugate vaccine----[1] 14
44H.P. Acthar® Gel[1] Corticotropin[1] D00146 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 14
45HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)[1] Clostridium tetani toxoid antigen (formaldehyde inactivated)---[2] 13, 14
46Haemophilus type b vaccine (conjugated)----[1] 14
47HB-adMSCs[1] Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---[5] 2, 6, 13, 14, 46
48Hematopoietic Stem Cell Transplantation----[12] 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285
49Hidrocloruro de fingolimod[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14
50Hizentra----[4] 14, 50, 51, 65
51Hizentra®[1] Human immunoglobulin G---[2] 14, 65
52HUMAN IMMUNOGLOBULIN G[1] Human immunoglobulin G---[4] 14, 50, 63, 65
53Human normal 10% immunoglobulin for intravenous administration[1] Human immunoglobulin G---[1] 14
54Human normal 10% immunoglobulin for intravenous administrationn[1] Human immunoglobulin G---[1] 14
55Human normal immunoglobulin[1] Human immunoglobulin G---[9] 11, 13, 14, 43, 45, 50, 51, 63, 65
56HUMAN NORMAL IMMUNOGLOBULIN (IV)[1] Human immunoglobulin G---[4] 11, 14, 63, 65
57Human normal immunoglobulin (IVIg)[1] Human immunoglobulin G---[3] 14, 50, 65
58Human normal immunoglobulin (SCIg)[1] Human immunoglobulin G---[1] 14
59Human normal immunoglobulin for intravenous administration[1] Human immunoglobulin G---[3] 14, 51, 65
60Human normal immunoglobulin G (IgG > 98% purity)[1] Human immunoglobulin G---[3] 14, 63, 65
61Hyaluronidase[1] Hyaluronidase[3] D04455 ,
D04456 ,
D06604 		--[5] 14, 28, 51, 65, 331
62HyQvia[1] Hyaluronidase (human recombinant)---[2] 14, 65
63I10----[1] 14
64I10E----[3] 14, 63, 65
65IGIV, 10%----[2] 14, 65
66IgPro10----[3] 14, 51, 65
67IgPro20----[4] 14, 50, 51, 65
68IgPro20 (high dose)----[1] 14
69IgPro20 (low dose)----[1] 14
70IGVENA*FL 200ML 10G+SET----[2] 14, 50
71Immune globulin----[3] 11, 13, 14
72Immune Globulin 10% Intravenous Solution----[1] 14
73Immune Globulin Intravenous (human), 10%----[2] 14, 65
74Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified----[1] 14
75Immune Globulin Subcutaneous (Human)----[2] 14, 65
76Immunoglobulin----[3] 13, 14, 63
77IMMUNOGLOBULIN G----[8] 2, 11, 13, 14, 49, 50, 63, 65
78Immunoglobulin perfusion----[1] 14
79IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa----[1] 14
80Immunoglobuline G----[1] 14
81Immunoglobulins----[1] 14
82Immunoglobulins, normal human, for extravascular adm.----[1] 14
83Immunoglobulins, normal human, for intravascular adm.----[2] 14, 15
84Intratect----[4] 13, 14, 35, 65
85Intravenous immune globulin G----[1] 14
86Intravenous Immunoglobulin----[7] 13, 14, 35, 38, 39, 51, 309
87Intravenous immunoglobulin (IVIg)[1] Human immunoglobulin G---[4] 14, 17, 164, 296
88IQYMUNE----[1] 14
89IVIG[1] Human immunoglobulin G---[7] 11, 13, 14, 17, 50, 51, 65
90J07AH07----[1] 14
91KIOVIG[1] Human immunoglobulin G---[2] 14, 65
92KIOVIG 100 mg/ml solution for infusion[1] Human immunoglobulin G---[2] 14, 65
93Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)[1] Human immunoglobulin G---[1] 14
94Lipoic acid[1] Lipoic acid---[5] 2, 5, 13, 14, 20
95MabThera[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271
96MABTHERA - 1 FIALA 500 MG 50 ML[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 14, 53
97MD1003----[5] 2, 10, 13, 14, 20
98Melphalan[1] Melphalan[1] D00369 --[15] 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
99Menjugate----[1] 14
100Methylprednisolon[1] Methylprednisolone[1] D00407 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[4] 13, 14, 51, 66
101Methylprednisolon (Solu-Medrol)[1] Methylprednisolone[1] D00407 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 14
102Methylprednisolone[1] Methylprednisolone[1] D00407 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[46] 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
103Methylprednisolone (Solu-Medrol)[1] Methylprednisolone[1] D00407 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 14
104Metilprednisolone sodio succinato----[3] 13, 14, 56
105N. MENINGITIDIS GROUP C POLYSACCHARIDE----[1] 14
106NewGam----[3] 14, 63, 65
107Nipocalimab[1] Nipocalimab[1] D11666 [1] FCGRT 💬-[6] 11, 14, 46, 49, 53, 61
108NPB-01----[3] 13, 14, 162
109PANZYGA----[1] 14
110PARACETAMOLO----[9] 2, 11, 14, 19, 28, 53, 61, 63, 300
111Placebo----[28] 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
112PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----[2] 13, 14
113PREDNISOLONE[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[42] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
114Prednisone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[45] 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
115Prevenar 13[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[5] 13, 14, 46, 96, 222
116Prevenar 13 sospensione per iniezione[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[1] 14
117PRIVIGEN[1] Human immunoglobulin G---[4] 11, 14, 51, 65
118Privigen®[1] Human immunoglobulin G---[3] 14, 63, 65
119Recombinant human hyaluronidase[2] Hyaluronidase,
Hyaluronidase (human recombinant)		[3] D04455 ,
D04456 ,
D06604 		--[3] 14, 28, 65
120RHuPH20----[2] 13, 14
121RITUXIMAB[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[48] 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
122Rituximab (genetical recombination)[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 14
123ROZANOLIXIZUMAB[1] Rozanolixizumab[1] D12182 [1] FCGRT 💬-[3] 11, 14, 63
124RVG 51680----[1] 14
125RVG 56083----[1] 14
126SAR445088 (formerly BIVV020)----[1] 14
127SAR445088 (IV)----[1] 14
128SAR445088 (SC)----[1] 14
129Sodium chloride[2] Chloride ion,
Sodium chloride		[1] D02056 --[20] 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299
130Sodium Chloride 0.9%[2] Chloride ion,
Sodium chloride		[1] D02056 --[2] 14, 227
131SOLIRIS[1] Eculizumab[1] D03940 [1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[7] 11, 13, 14, 61, 62, 109, 222
132SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----[3] 13, 14, 53
133Subcutaneous immune globulin G----[1] 14
134Subcutaneous immunoglobulin----[1] 14
135Subcuvia----[3] 14, 49, 65
136TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE----[1] 14
137TAK-771----[2] 14, 65
138Tetanus toxoid[1] Clostridium tetani toxoid antigen (formaldehyde inactivated)---[4] 13, 14, 46, 50
139TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML----[1] 14
140UCB7665----[3] 11, 14, 63
141VACCINO PNEUMOCOCCICO SACCARIDICO----[1] 14
142Vivaglobin----[2] 14, 65